Deerfield Management Company »

Quidel Corp shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Quidel Corp (QDEL) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Quidel Corp

Tip: Access up to 7 years of quarterly data

All positions including Quidel Corp held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quidel Corp by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $26M 348k 73.70
2023-09-30 $11M 150k 73.04

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Quidel Corp

Carlyle
Vanguard Group
Rima Management
Arrowpoint Asset Management
Jpmorgan Chase & Co
Lgt Capital Partners
Dimensional Fund Advisors
Kempen Capital Management
Neuberger Berman Group
LSV Asset Management
Massachusetts Financial Services
Wellington Management Company
Bank of New York Mellon
Charles Schwab Investment Management
Norges Bank Investment Management

View all funds holding Quidel Corp